[go: up one dir, main page]

NO20070757L - Ny sekvens for forbedring av ekspresjon av nukleinsyre(r) - Google Patents

Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)

Info

Publication number
NO20070757L
NO20070757L NO20070757A NO20070757A NO20070757L NO 20070757 L NO20070757 L NO 20070757L NO 20070757 A NO20070757 A NO 20070757A NO 20070757 A NO20070757 A NO 20070757A NO 20070757 L NO20070757 L NO 20070757L
Authority
NO
Norway
Prior art keywords
nucleic acid
new sequence
enhancing expression
expression
repressor
Prior art date
Application number
NO20070757A
Other languages
English (en)
Other versions
NO341862B1 (no
Inventor
Arie Pieter Otte
Theodorus Hendrikus Jaco Kwaks
Richard George Antonius Sewalt
Henricus Johannes Mar Blokland
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20070757(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Publication of NO20070757L publication Critical patent/NO20070757L/no
Publication of NO341862B1 publication Critical patent/NO341862B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen skaffer til veie et nytt anti-repressorelement, som er anvendelig for å forbedre ekspresjonen av nukleinsyrer i en vertscelle. Metoder som anvender det nye anti-repressorelementet for å produsere et protein av interesse er også fremskaffet. Oppfinnelsen skaffer også til veie nye konfigurasjoner av ekspresjons-kassetter som består av anti-repressorelementer.
NO20070757A 2004-07-08 2007-02-08 Ny sekvens for forbedring av ekspresjon av nukleinsyre(r) NO341862B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58700704P 2004-07-08 2004-07-08
EP2004051405 2004-07-08
PCT/EP2005/053251 WO2006005718A2 (en) 2004-07-08 2005-07-07 Novel sequence for improving expression of nucleic acid

Publications (2)

Publication Number Publication Date
NO20070757L true NO20070757L (no) 2007-02-08
NO341862B1 NO341862B1 (no) 2018-02-12

Family

ID=34971366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070757A NO341862B1 (no) 2004-07-08 2007-02-08 Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)

Country Status (19)

Country Link
US (1) US7825232B2 (no)
JP (1) JP4805262B2 (no)
KR (1) KR101188013B1 (no)
CN (1) CN1981057B (no)
AT (1) ATE378426T1 (no)
AU (1) AU2005261699B2 (no)
BR (1) BRPI0512798A (no)
CA (1) CA2573022C (no)
DE (1) DE602005003369T2 (no)
DK (1) DK1763586T3 (no)
EA (1) EA011747B1 (no)
ES (1) ES2296201T3 (no)
IL (1) IL180531A (no)
MX (1) MXPA06014553A (no)
NO (1) NO341862B1 (no)
NZ (1) NZ551510A (no)
PT (1) PT1763586E (no)
WO (1) WO2006005718A2 (no)
ZA (1) ZA200610470B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1572994T3 (da) 2002-12-20 2007-05-29 Chromagenics Bv Midler og fremgangsmåder til fremstilling af en protein gennem chromatinåbnere, som kan göre chromatin mere tilgængeligt for transkriptionsfaktorer
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
AU2005300503B2 (en) * 2004-11-08 2010-12-16 Chromagenics B.V. Selection of host cells expressing protein at high levels
US8039230B2 (en) 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
ES2384391T3 (es) * 2004-11-08 2012-07-04 Chromagenics B.V. Selección de células hospedantes que expresan proteína a altos niveles
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
US9284563B2 (en) 2009-06-15 2016-03-15 Cellagenics B.V. Stringent selectable markers
BR112012031694A2 (pt) 2010-06-15 2016-02-16 Cellagenics B V fragmento de ácido nucleíco, construto de ácido nucleíco, vetor de expressão, célula hospedeira, método de geração de uma célula hospedeira para a expressão de um produto gênico de interesse, e, método de expresão de um produto de gene de interesse
CN103180443B (zh) 2010-09-01 2016-01-13 萨拉基尼克有限公司 用于增强基因表达的来自核糖体蛋白启动子的核酸片段
CN110484563B (zh) * 2019-07-25 2023-04-07 新乡医学院 哺乳动物细胞组合表达载体、表达系统、制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274045T3 (es) * 2001-07-04 2007-05-16 Chromagenics B.V. Secuencias de adn que comprenden cualidades moduladoras de la transcripcion genetica y metodos de deteccion y utilizacion de estas secuencias de adn.
CA2723500C (en) * 2002-06-14 2014-10-28 Chromagenics B.V. A method for simultaneous production of multiple proteins; vectors and cells for use therein
DK1572994T3 (da) 2002-12-20 2007-05-29 Chromagenics Bv Midler og fremgangsmåder til fremstilling af en protein gennem chromatinåbnere, som kan göre chromatin mere tilgængeligt for transkriptionsfaktorer

Also Published As

Publication number Publication date
WO2006005718A3 (en) 2006-08-17
DE602005003369T2 (de) 2009-03-05
CN1981057B (zh) 2012-07-04
ZA200610470B (en) 2008-09-25
BRPI0512798A (pt) 2008-04-08
DK1763586T3 (da) 2008-03-17
AU2005261699B2 (en) 2009-07-23
ATE378426T1 (de) 2007-11-15
JP2008505626A (ja) 2008-02-28
AU2005261699A1 (en) 2006-01-19
EA200700233A1 (ru) 2007-06-29
CA2573022C (en) 2012-03-06
DE602005003369D1 (de) 2007-12-27
CA2573022A1 (en) 2006-01-19
US20070212755A1 (en) 2007-09-13
KR101188013B1 (ko) 2012-10-08
WO2006005718A2 (en) 2006-01-19
CN1981057A (zh) 2007-06-13
MXPA06014553A (es) 2007-03-12
US7825232B2 (en) 2010-11-02
PT1763586E (pt) 2008-02-25
ES2296201T3 (es) 2008-04-16
IL180531A (en) 2011-04-28
NZ551510A (en) 2009-10-30
JP4805262B2 (ja) 2011-11-02
EA011747B1 (ru) 2009-06-30
KR20070042122A (ko) 2007-04-20
IL180531A0 (en) 2007-06-03
NO341862B1 (no) 2018-02-12
HK1097004A1 (en) 2007-06-15

Similar Documents

Publication Publication Date Title
NO20070757L (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
ATE480643T1 (de) Homogener nachweis von analyten
EP2295555A3 (en) Polypeptides having lipase activity and polynucleotides encodig same
ATE530643T1 (de) Säureaktive fungale protease
DK1448595T3 (da) Antimikrobielle polypeptider
DK1836299T3 (da) Polypeptider, der har cellobiohydrolaseaktivitet, og polynekleotider, der koder for disse
WO2005074647A3 (en) Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
DE60330842D1 (de) Für den nachweis von nukleinsäuren kompetente biologische rohderivate
WO2006047469A8 (en) Polypeptides having lipase activity and polynucleotides encoding same
DE60313659D1 (de) Borrelidin-derivate und ihre medizinische anwendung
ATE532861T1 (de) Expressionsvektor
ATE488591T1 (de) Neuer l-lysin-induzierbarer promotor
ATE463572T1 (de) Rekombinanter faktor viii mit erhöhter spezifischer aktivität
TW200510460A (en) Antimicrobial polypeptides
WO2005067648A3 (en) Multiplex spatial profiling of gene expression
ATE445009T1 (de) Signalpeptid zur herstellung eines polypeptids
WO2008002548A3 (en) Novel human acidic mammalian chitinase and use thereof
ATE486127T1 (de) Wiederherstellung der aktivität von 5- enolpyruvylshikimat-3-phosphat-synthase durch fragmentkomplementierung
WO2006014490A3 (en) Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
ATE414905T1 (de) Diabetesmodell
DK1639110T3 (da) Rajgræspollenspecifikke promotorer og ekspressionskonstructer
EA200702009A1 (ru) Усовершенствованный способ экспрессирующего клонирования в клетке-хозяине
WO2004065554A3 (en) Human saa3 nucleic acid molecule, protein, and methods of use for same
WO2002063009A8 (en) Lp mammalian proteins; related reagents
WO2003104478A3 (en) Detection of rna structural elements

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees